Skip to content
healthcare.dev

IDVYNSO

NDC 0006-5092, Doravirine, Islatravir, tablet, film coated, from Merck Sharp & Dohme LLC.

Product NDC
0006-5092
Status
Listed
Labeler
Merck Sharp & Dohme LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216964
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0006-5092 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DORAVIRINE100 mg/1
  • ISLATRAVIR ANHYDROUS.25 mg/1

Pharmacologic classes

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
0006-5092-010000650920130 TABLET, FILM COATED in 1 BOTTLE (0006-5092-01)
0006-5092-590000650925914 TABLET, FILM COATED in 1 BOTTLE (0006-5092-59)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/11aaeb53-9848-433c-be7f-db8a5bc0b26f

Use it

Look up 0006-5092 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0006-5092 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0006-5092. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.